CN1150015C - Medicine for treating leucocytopenia caused by lupus erythematosus - Google Patents
Medicine for treating leucocytopenia caused by lupus erythematosus Download PDFInfo
- Publication number
- CN1150015C CN1150015C CNB01104487XA CN01104487A CN1150015C CN 1150015 C CN1150015 C CN 1150015C CN B01104487X A CNB01104487X A CN B01104487XA CN 01104487 A CN01104487 A CN 01104487A CN 1150015 C CN1150015 C CN 1150015C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- caused
- root
- lupus erythematosus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Abstract
The present invention relates to a medicine for treating cytopenia caused by immunological disease, such as lupus erythematosus, etc., or leukopenia caused by medicine. The medicine is formed by preparing Chinese herbal medicine, such as tangshen, heterophylly falsestarwort root, saute largehead atractylodes rhizome, ganoderma lucidum, white hyacinth bean, suberect spatholobus, glossy privet fruit, slenderstyle acanthopanax bark, rehmannia root, flowery knotweed, cape, ledebouriella root, milkvetch root, antelope horn, perilla, endothelium corneum gigeriae galli, donkey-hide gelatin, etc., and can obviously improve white blood cell hypofunction symptoms caused by various immunological diseases.
Description
The present invention relates to a kind ofly treat that cell that the lupus erythematosus immune disease caused reduces or because of the medicine of drug-induced leukopenia.Specifically be with the Chinese herbal medicine be raw material according to the Chinese patent medicine that certain prepared forms, belong to the field of Chinese medicines.
Systemic lupus erythematosus (sle) is that world's medical matters circle are referred to as one of four big difficult disease of wrecking the human life, and domestic and international interrelated data report, the sickness rate that every year should disease to be rapidly increasing progressively by a relatively large margin, to the mankind's threat not second to cancer and acquired immune deficiency syndrome (AIDS).In areas such as the Luo Qisite of the U.S., California, the sickness rate in its members of the same clan exceeds hundreds of times of general crowd up to 0.4-5%.Black people's sickness rate is three times in general crowd, and in the Black women of 15-45, per 245 people have a people to suffer from lupus erythematosus, is more common in the 15-25 young women in year especially.Before not using the 17-hydroxy-11-dehydrocorticosterone treatment, the primary disease mortality rate is very high, 80% patient dies from primary disease in 2 years, in recent years because the progress of diagnostic techniques and utilization 17-hydroxy-11-dehydrocorticosterone, the utilization of immunosuppressant, levamisole, antiviral drugs, antilymphocyte globulin thymosin and Chinese herbal medicine, the primary disease mortality rate progressively descends, and best survival rate has reached 80-85% in present 10 years.Though change is arranged, but, still have the part patient to die from organa parenchymatosums such as the heart, kidney, the brain infringement and the complication of primary disease because of various factors, hormone and the immunosuppressant of using both at home and abroad brought potential infection and transition to use this type of medicine to suppress the normal immunologic function of body to patient at present, destroyed organism balance, the patient is caused a disease because of lupus erythematosus, is exactly to cause death because of side effects of pharmaceutical drugs.Particularly, systemic lupus erythematosus (sle) is the autoimmune disease that causes multiple organ injury, often causes leukopenia clinically, brings very big misery to patient, and lacks the active drug of the concurrent leukopenia of treatment lupus erythematosus on the market.
Therefore, the object of the invention provides a kind of medicine for the treatment of leucocytopenia caused by lupus erythematosus.
Medicine of the present invention is that the Chinese herbal medicine by the following weight proportioning forms according to certain prepared:
Radix Codonopsis 12-18
Radix Pseudostellariae 12-18
Semen Lablab Album 10-15
Ganoderma 12-18
Rhizoma Atractylodis Macrocephalae (parched) 10-15
Caulis Spatholobi 20-35
Fructus Ligustri Lucidi 12-18
Cortex Acanthopancis 12-18
Radix Rehmanniae 15-25
Radix Polygoni Multiflori 10-18
Stir-baked SQUAMA MANITIS 15-20
Radix Saposhnikoviae 10-15
Radix Astragali 15-25
Cornu Saigae Tataricae 6-15
Folium Perillae 10-15
Endothelium Corneum Gigeriae Galli 10-15
Colla Corii Asini 10-15
Medicine of the present invention preferably is prepared from by the Chinese medicine of following weight parts:
Radix Codonopsis 15
Radix Pseudostellariae 15
Semen Lablab Album 12
Ganoderma 15
Rhizoma Atractylodis Macrocephalae (parched) 12
Caulis Spatholobi 28
Fructus Ligustri Lucidi 15
Cortex Acanthopancis 15
The Radix Rehmanniae 20
The Radix Polygoni Multiflori 15
Stir-baked SQUAMA MANITIS 18
Radix Saposhnikoviae 12
The Radix Astragali 18
Cornu Saigae Tataricae 10
Folium Perillae 12
Endothelium Corneum Gigeriae Galli 12
Colla Corii Asini 12
In the middle of the above-mentioned raw materials medicine of the present invention, Cornu Saigae Tataricae can replace with Cornu Bubali.
Medicine of the present invention can be prepared into pharmaceutical dosage form commonly used clinically according to common process, preferred capsule.
Medicine of the present invention is on raw material is formed, and compatibility is reasonable, Radix Codonopsis, Radix Pseudostellariae, Semen Lablab Album, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali invigorating the spleen and benefiting QI in the side, and invigorating QI to consolidate the body surface resistance, the assistant Radix Saposhnikoviae is with the source of inspirationization life; The Radix Rehmanniae, Fructus Ligustri Lucidi, Caulis Spatholobi, the Radix Polygoni Multiflori, Colla Corii Asini nourishing blood are invigorated blood circulation, nourishing YIN and clearing heat; Cortex Acanthopancis closes the moon of the Radix Polygoni Multiflori, the flat invigorating the liver and kidney of Fructus Ligustri Lucidi; Cornu Saigae Tataricae symphysis ground, increasing the merit of heat-clearing and toxic substances removing, stir-baked SQUAMA MANITIS gas raw meat and scurrying, the property that it walks to scurry, very careful, so can declare logical internal organs, reach the pass key thoroughly, the modern medicine test confirms this product energy leukocyte increasing, and good hemostatic function is arranged, the Endothelium Corneum Gigeriae Galli promoting digestion and invigorating the stomach, to help the fortuneization of the efficacy of a drug, all medicines share, " qi being the governor of blood; blood is the dominator of QI " thought in invigorating the spleen and benefiting QI, giving young employees remedial-courses in general knowledge and vocational skills QI and blood, the traditional Chinese medical science, " spleen is for changing the source of angry blood ".Be used for the treatment of leukopenia with the clinical drug of above-mentioned preparation of compositions better curative effect is arranged.
Embodiment:
Choose raw material according to following composition
Radix Codonopsis 15
Radix Pseudostellariae 15
Semen Lablab Album 12
Ganoderma 15
Rhizoma Atractylodis Macrocephalae (parched) 12
Caulis Spatholobi 28
Fructus Ligustri Lucidi 15
Cortex Acanthopancis 15
The Radix Rehmanniae 20
The Radix Polygoni Multiflori 15
Stir-baked SQUAMA MANITIS 18
Radix Saposhnikoviae 12
The Radix Astragali 18
Cornu Saigae Tataricae 10
Folium Perillae 12
Endothelium Corneum Gigeriae Galli 12
Colla Corii Asini 12
With said medicine, pick up decontamination, clean, add water and do not have powder, decoct twice, each 1 hour, merge decoction liquor twice, concentrate fluid extract, add appropriate amount of starch, pelletize, tabletting promptly makes tablet.
Claims (2)
1, a kind of medicine for the treatment of leucocytopenia caused by lupus erythematosus is characterized in that this medicine is that Chinese medicine by following weight parts is prepared from:
Radix Codonopsis 12-18
Radix Pseudostellariae 12-18
Semen Lablab Album 10-15
Ganoderma 12-18
Rhizoma Atractylodis Macrocephalae (parched) 10-15
Caulis Spatholobi 20-35
Fructus Ligustri Lucidi 12-18
Cortex Acanthopancis 12-18
Radix Rehmanniae 15-25
Radix Polygoni Multiflori 10-18
Stir-baked SQUAMA MANITIS 15-20
Radix Saposhnikoviae 10-15
Radix Astragali 15-25
Cornu Saigae Tataricae 6-15
Folium Perillae 10-15
Endothelium Corneum Gigeriae Galli 10-15
Colla Corii Asini 10-15.
2, medicine according to claim 1 is characterized in that this medicine is that Chinese medicine by following weight parts is prepared from:
Radix Codonopsis 15
Radix Pseudostellariae 15
Semen Lablab Album 12
Ganoderma 15
Rhizoma Atractylodis Macrocephalae (parched) 12
Caulis Spatholobi 28
Fructus Ligustri Lucidi 15
Cortex Acanthopancis 15
The Radix Rehmanniae 20
The Radix Polygoni Multiflori 15
Stir-baked SQUAMA MANITIS 18
Radix Saposhnikoviae 12
The Radix Astragali 18
Cornu Saigae Tataricae 10
Folium Perillae 12
Endothelium Corneum Gigeriae Galli 12
Colla Corii Asini 12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01104487XA CN1150015C (en) | 2001-02-27 | 2001-02-27 | Medicine for treating leucocytopenia caused by lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01104487XA CN1150015C (en) | 2001-02-27 | 2001-02-27 | Medicine for treating leucocytopenia caused by lupus erythematosus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1310009A CN1310009A (en) | 2001-08-29 |
| CN1150015C true CN1150015C (en) | 2004-05-19 |
Family
ID=4653943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB01104487XA Expired - Lifetime CN1150015C (en) | 2001-02-27 | 2001-02-27 | Medicine for treating leucocytopenia caused by lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1150015C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100335096C (en) * | 2003-06-03 | 2007-09-05 | 霍玉书 | Anti-allergic traditional Chinese medicine composition and preparing method thereof |
-
2001
- 2001-02-27 CN CNB01104487XA patent/CN1150015C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1310009A (en) | 2001-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1044974C (en) | Anti- hepatitis B preparation | |
| CN1188158C (en) | Medicines composition for raising body's immunity and its prepn | |
| CN1255181C (en) | Preparation of medicinal composition for nourishing | |
| CN1048498A (en) | The manufacture method of the compositions of treatment immunologic function deficiency disease | |
| CN1256133C (en) | Antifatigue Chinese medicine composition and its prepn process | |
| CN1806834A (en) | Chinese medicine for treating AIDS | |
| CN1232279C (en) | Antilipemic Chinese medicine | |
| CN1150015C (en) | Medicine for treating leucocytopenia caused by lupus erythematosus | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1285380C (en) | Chinese patent medicines for treating chronic superficial gastritis (epigastric pain) and preparation method thereof | |
| CN1107711A (en) | Hypoglycemic compound capsule | |
| CN1242767C (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN1055021C (en) | Chinese medicine capsule for nephritis | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1186042C (en) | Chinese medicine composition for curing AIDS and its preparation mehtod | |
| CN1150014C (en) | Lupus erythematosus treating medicine | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN1140281C (en) | Yiyuansan powder as one orally taken medicine for treating liver cancer and its preparation | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1059590C (en) | Medicine for blood generation and preparing method | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040519 |